General Archive

-
News releases
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
MRC Technology is pleased to highlight that today Merck, known as MSD outside the United States and Canada, announced FDA…
-
News releases
TYSABRI gains market approval
Biogen Idec and Elan Corporation yesterday announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food…
